Related Experiment Video

Updated: Jul 17, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Hypoglycemia in the neonate

Charles A Stanley1

  • 1Division Chief of Endocrinology/Diabetes, Children's Hospital of Philadelphia, Professor of Pediatrics, University of Pennsylvania School of Medicine, 34th Street and Civic Center Blvd, Philadelphia, PA 19104, USA.

Pediatric Endocrinology Reviews : PER
|January 31, 2007
PubMed

Insights

Neonatal hypoglycemia, often caused by transient immaturity or persistent hyperinsulinism (HI), requires specific diagnosis and treatment. Medical or surgical interventions are tailored to the type of HI for effective management in newborns.

Area of Science:

  • Neonatal Medicine
  • Endocrinology
  • Genetics

Background:

  • Neonatal hypoglycemia can stem from immature glucoregulatory pathways, typically resolving with feeding.
  • Persistent hyperinsulinism (HI) is a common cause of neonatal hypoglycemia, often remitting spontaneously, especially in preterm or stressed infants.
  • Congenital hyperinsulinism (CHI) presents with non-remitting hypoglycemia, necessitating targeted interventions.

Purpose of the Study:

  • To outline the causes and management strategies for neonatal hypoglycemia.
  • To differentiate between transient and persistent forms of hyperinsulinism.
  • To emphasize the importance of disease-specific diagnosis for effective treatment of neonatal hyperinsulinism.

Main Methods:

  • Review of literature on neonatal hypoglycemia and hyperinsulinism.
  • Analysis of treatment modalities including feeding, diazoxide, and surgery.
  • Classification of hyperinsulinism based on genetic mutations and histological subtypes (focal vs. diffuse).

Main Results:

  • Transient neonatal hypoglycemia usually resolves with normal feeding.
  • Diazoxide is effective for many cases of persistent hyperinsulinism, particularly in low birth weight or stressed neonates.
  • Congenital hyperinsulinism unresponsive to diazoxide may require surgery, with extent determined by focal or diffuse disease patterns.

Conclusions:

  • Accurate diagnosis of hyperinsulinism subtypes is crucial for appropriate management.
  • Treatment strategies for neonatal hypoglycemia range from supportive care to medical therapy and surgical intervention.
  • Understanding genetic and histological factors guides the selection of optimal treatment for neonatal hyperinsulinism.

More Related Videos

Biochemical Measurement of Neonatal Hypoxia13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes: